Abstract
The development of nanomedicine has the potential to revolutionise care and treatment of patients. However the rise of this new technology has been subject to considerable controversy. The EU itself while promoting the development of nanomedicine and nanotechnology has become increasingly concerned to address some of the reservations which have been expressed regarding this technology. This paper explores what legal, ethical and regulatory challenges are posed by nanomedicine, how the EU has engaged with these to date and how EU law and policy in this area may develop in the future.
Get full access to this article
View all access options for this article.